CIK 2092021
Seven Fleet Capital Management LP
Institutional 13F holdings & portfolio
Holdings
85
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 51–85 of 85
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| TARS | TARSUS PHARMACEUTICALS INC | 5K | $100K–$500K | SH |
| PLRX | PLIANT THERAPEUTICS INC | 277K | $100K–$500K | SH |
| ACRS | ACLARIS THERAPEUTICS INC | 107K | $100K–$500K | SH |
| SEPN | SEPTERNA INC | 11K | $100K–$500K | SH |
| CLYM | CLIMB BIO INC | 76K | $100K–$500K | SH |
| CMPS | COMPASS PATHWAYS PLC | 40K | $100K–$500K | SH |
| ENTX | ENTERA BIO LTD | 135K | $100K–$500K | SH |
| VKTX | VIKING THERAPEUTICS INC | 6K | $100K–$500K | SH |
| QURE | UNIQURE NV | 9K | $100K–$500K | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 49K | $100K–$500K | SH |
| OCUL | OCULAR THERAPEUTIX INC | 17K | $100K–$500K | SH |
| ELVN | ENLIVEN THERAPEUTICS INC | 12K | $100K–$500K | SH |
| ORKA | ORUKA THERAPEUTICS INC | 5K | $100K–$500K | SH |
| ASMB | ASSEMBLY BIOSCIENCES INC | 4K | $100K–$500K | SH |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 4K | $100K–$500K | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 12K | $100K–$500K | SH |
| APGE | APOGEE THERAPEUTICS INC | 2K | $100K–$500K | SH |
| ALXO | ALX ONCOLOGY HLDGS INC | 118K | $100K–$500K | SH |
| VSTM | VERASTEM INC | 15K | $100K–$500K | SH |
| RGC | REGENCELL BIOSCIENCE HLDGS L | 4K | $50K–$100K | SH |
| TRVI | TREVI THERAPEUTICS INC | 7K | $50K–$100K | SH |
| IMUX | IMMUNIC INC | 155K | $50K–$100K | SH |
| PMVP | PMV PHARMACEUTICALS INC | 63K | $50K–$100K | SH |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4K | $50K–$100K | SH |
| TRAW | TRAWS PHARMA INC | 49K | $50K–$100K | SH |
| ATXS | ASTRIA THERAPEUTICS INC | 4K | $50K–$100K | SH |
| EWTX | EDGEWISE THERAPEUTICS INC | 2K | $15K–$50K | SH |
| VTGN | VISTAGEN THERAPEUTICS INC | 63K | $15K–$50K | SH |
| ENTA | ENANTA PHARMACEUTICALS INC | 2K | $15K–$50K | SH |
| CGEM | CULLINAN THERAPEUTICS INC | 3K | $15K–$50K | SH |
| GBIO | GENERATION BIO CO | 5K | $15K–$50K | SH |
| BEAM | BEAM THERAPEUTICS INC | 337 | $1K–$15K | SH |
| ELDN | ELEDON PHARMACEUTICALS ORD | 6K | $1K–$15K | SH |
| ABVX | ABIVAX SA | 12 | $1K–$15K | SH |
| VIR | VIR BIOTECHNOLOGY INC | 200 | $1K–$15K | SH |